13F Data
13F filer · CIK 1831942

Commodore Capital LP

NEW YORK, NY · filing since Q4 2020 · last filing Aug 14, 2026
Reported value
$1.7B
$-49.5M vs prior
Positions
33
New / sold out
5 / 8
Added / reduced
6 / 9
Turnover
10.7%
buys $182.8M · sells $726.0M
Top-10 weight
68.2%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewTANGO THERAPEUTICS INC+2,250,000–+$70.3M
NewEDITAS MEDICINE INC+8,889,000–+$28.8M
AddedEYEPOINT INC+1,775,000+62.8%+$25.4M
NewINFLARX NV+7,300,000–+$16.4M
AddedASSEMBLY BIOSCIENCES INC+415,000+41.5%+$11.4M
AddedAVALO THERAPEUTICS INC+535,319+110.8%+$9.9M
AddedCOGENT BIOSCIENCES INC+161,993+5.6%+$6.3M
AddedRELMADA THERAPEUTICS INC+791,099+124.8%+$5.5M
NewRESEARCH ALLIANCE CORP III+500,000–+$5.3M
AddedAN2 THERAPEUTICS INC+599,967+25.7%+$2.9M
1 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedSPYRE THERAPEUTICS INC-1,065,594-55.7%$-94.6M
ReducedRELAY THERAPEUTICS INC-5,000,000-29.4%$-93.5M
ReducedNUVALENT INC-733,600-88.0%$-90.6M
ReducedALKERMES PLC-1,200,000-28.6%$-62.9M
ReducedKYMERA THERAPEUTICS INC-500,000-66.7%$-57.3M
Sold outERASCA INC-3,175,000-100.0%$-51.4M
ReducedCELLDEX THERAPEUTICS INC NEW-1,346,616-49.9%$-50.1M
Sold outXENON PHARMACEUTICALS INC-825,000-100.0%$-48.0M
Sold outNURIX THERAPEUTICS INC-2,275,000-100.0%$-35.3M
Sold outCORVUS PHARMACEUTICALS INC-2,258,735-100.0%$-33.0M
7 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $183.9MQ1 2021: $251.0MQ2 2021: $287.0MQ3 2021: $379.3MQ4 2021: $431.8MQ1 2022: $447.7MQ2 2022: $473.0MQ3 2022: $621.9MQ4 2022: $663.5MQ1 2023: $656.8MQ2 2023: $889.8MQ3 2023: $855.5MQ4 2023: $1.1BQ1 2024: $1.5BQ2 2024: $1.5BQ3 2024: $1.6BQ4 2024: $1.4BQ1 2025: $1.4BQ2 2025: $1.4BQ3 2025: $2.0BQ4 2025: $1.5BQ1 2026: $1.7BQ2 2026: $1.7B
Q4 2020Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1RELAY THERAPEUTICS INCCOM12,000,000$224.5M13.37%
2ENLIVEN THERAPEUTICS INCCOM3,275,000$166.2M9.90%
3ALKERMES PLCSHS3,000,000$157.2M9.36%
4COGENT BIOSCIENCES INCCOM3,050,000$118.0M7.03%
5AMYLYX PHARMACEUTICALS INCCOM5,650,000$101.5M6.04%
6DEFINIUM THERAPEUTICS INCCOM SHS2,000,000$94.1M5.60%
7SPYRE THERAPEUTICS INCCOM NEW846,786$75.2M4.48%
8ALTO NEUROSCIENCE INCCOM SHS2,723,196$71.9M4.28%
9TANGO THERAPEUTICS INCCOM2,250,000$70.3M4.19%
10EYEPOINT INCCOM NEW4,600,000$65.8M3.92%
23 more rows. Subscribe for $29/month to see every row, download the data and use the API.